Ironwood Pharmaceuticals (IRWD) Net Margin Growth (3y) (2013 - 2026)

Ironwood Pharmaceuticals (IRWD) Net Margin Growth (3y) (2013 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Margin Growth (3y) (Qtr)
1 Haleon 87.22 Bn 85.35 Bn - -
2 Teva Pharmaceutical Industries 39.60 Bn 35.87 Bn 1.97 Bn 1,620.00
3 Zoetis 31.46 Bn 29.52 Bn 1.62 Bn -98.00
4 Takeda Pharmaceutical 26.49 Bn 22.44 Bn 4.39 Bn -4,358.00
5 United Therapeutics 23.03 Bn 20.88 Bn 648.10 Mn -1,235.00
6 Universe Pharmaceuticals 23.03 Bn -10.56 Bn - -
7 Viatris 20.90 Bn 19.09 Bn 1.16 Bn -100.00
8 Neurocrine Biosciences 17.50 Bn 16.19 Bn 800.70 Mn 4,252.00
9 Elanco Animal Health 12.33 Bn 11.91 Bn 785.00 Mn -404.00
10 Ironwood Pharmaceuticals 619.48 Mn 399.01 Mn - -565.00

Historic Data

Download Data
DateValue
Mar 31, 2026 -565.00
Dec 31, 2025 -46,056.00
Sep 30, 2025 -1,348.00
Jun 30, 2025 -1,045.00
Mar 31, 2025 -13,065.00
Dec 31, 2024 13,563.00
Sep 30, 2024 -4,982.00
Jun 30, 2024 -37,702.00
Mar 31, 2024 -5,051.00
Dec 31, 2023 -16,282.00
Jun 30, 2023 -104,280.00
Mar 31, 2023 3,975.00
Mar 31, 2022 9,426.00
Dec 31, 2021 1.20 Mn
Sep 30, 2021 12,968.00
Jun 30, 2021 40,723.00
Mar 31, 2021 6,896.00
Dec 31, 2020 -3,598.00
Jun 30, 2020 10,434.00
Mar 31, 2020 10,483.00